Cumberland Pharmaceuticals (CPIX) Selling, General & Administrative (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.56 Mn | 112.69 Mn | - | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.55 Mn |
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 3.44 Mn |
| Sep 30, 2023 | 2.34 Mn |
| Jun 30, 2023 | 2.37 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 3.51 Mn |
| Sep 30, 2022 | 2.17 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 2.30 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 2.04 Mn |